• awesomeicons6/solid/lock 100% Secure Online Payments

Anti-Human DR3/TNFRSF25

Anti-Human DR3/TNFRSF25 (D351-GRP)

Products

Sort by arrow-down-short-wide arrow-up-short-wide
Cat #
Size
Price
Cat # Size
chevron-left chevron-right
of

Description

Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domain containing receptors, TNFR1 and Fas. A novel cell death receptor was recently identified by several groups independently and designated DR3, Wsl-1, Apo-3, TRAMP and LARD1-5. The ligand for this novel death receptor has been defined as TWEAK, also termed Apo3L. DR3 is highly expressed in the tissues enriched in lymphocytes including PBL, thymus and spleen. Like TNFR1, DR3 induces apoptosis and NF-κB activation.

Specifications

Manufacturer Leinco Technologies Inc
Manufacturer Cat# D351
Alternate Names Polyclonal Antibody Death Receptor 3 TNFRSF25 Wsl-1 Apo-3 TRAMP LARD DR3 Human DR3 Anti-Human DR3/TNFRSF25
Target Death Receptor 3
Antibody Type Polyclonal
Applications WB
Storage -20°C to -70°C